Scientists from Febit Look to Commercialize New Gene Synthesis Method Using Next-Gen Sequencing

The team is currently seeking investors and partners in order to spin out a new company and set up a facility for the gene synthesis service, which it believes it could begin offering within the next one to two years at a price of 6 to 9 cents per base pair.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.